Harrow Health, Inc. Eton Pharmaceuticals, Inc. (ETON) insider trading activity
Harrow Health, Inc. is > 10% Shareholder of Eton Pharmaceuticals, Inc.. Currently has a direct ownership of 1.98 Million shares of ETON, which is worth approximately $33 Million. The most recent transaction as insider was on Apr 12, 2021, when has been sold 1,518,000 shares (Common Stock) at a price of $7.0 per share, resulting in proceeds of $10,626,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.98M
0%
3M change
0%
12M change
Total Value Held
$33 Million
HHI
Harrow Health, Inc.
> 10% Shareholder
Nashville, TN